Assignee
BEIJING IMMUNOAH PHARMATECH CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
3 records- 0152US2025186583A1Fusion protein of cd137 antibody and cd40l and use thereofBEIJING IMMUNOAH PHARMATECH CO LTD·Filed 2023·Application pending·0 cites
- 0247US2025346665A1Anti-cldn18.2 antibody and application thereofBEIJING IMMUNOAH PHARMATECH CO LTD·Filed 2022·Application pending·0 cites
- 0344US2024352139A1Fusion protein targeting both cd3 and cd137, preparation method therefor and use thereofBEIJING IMMUNOAH PHARMATECH CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BEIJING IMMUNOAH PHARMATECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →